Venkat Reddy Mali

This inventor holds 60 USPTO granted patents and 6 published patent applications, plus 8 CIPO patents and 17 EPO patents, primarily in Immunomodulator Compounds (CPC class C07D). Top assignees: Chemocentryx, Inc., Metabasis Therapeutics, Inc., Abbvie Inc.. Active years: 2014-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkat Reddy Mali. Retrieved from https://idiyas.com/inventor/venkat-reddy-mali

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 60 (Patent Applications = 6)

% Patents Active = 91.7

CIPO Patents = 8 (Patent Applications = 10)

EPO Patents = 17 (Patent Applications = 17)

Average Co-Inventor Count = 9.1

ph-index = 7

Forward Citations = 251(Granted Patents)

Forward Citations (Not Self Cited) = 97(Dec 10, 2025)

Inventors with similar research interests:

Location History:

San Diego, CA (US) (2014 - 2020)
Cupertino, CA (US) (2014 - 2024)

Company Filing History:

Metabasis Therapeutics, Inc.

Years Active: 2014-2026

Loading Chart...

Areas of Expertise:

Immunomodulators

PD-L1 Inhibitors

CCR Antagonists

C5aR Inhibitors

Chemokine Receptors

Bruton's Tyrosine Kinase

Combination Therapy

Diacylglycerol O-Acyltransferase

Generalized Pustular Psoriasis

Triaryl Compounds

Substituted Anilines

Fused Bicyclic Compounds

60 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12533354 - Triaryl compounds for treatment of PD-L1 diseases (2026-01-27),

2. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors (2025-04-08),

3. 12172992 - Pyrimidines for degrading Bruton's tyrosine kinase (2024-12-24),

4. 12054484 - Substituted tetrahydropyrans as CCR2 modulators (2024-08-06),

5. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors (2024-06-18),

6. 11945805 - Inhibitors of CXCR2 (2024-04-02),

7. 11884654 - Substituted anilines as CCR(4) antagonists (2024-01-30),

8. 11872217 - Indanes as PD-L1 inhibitors (2024-01-16),

9. 11820759 - Modulators of chemokine receptors (2023-11-21),

10. 11807609 - Deuterated compounds as immunomodulators (2023-11-07),

11. 11773091 - 6-5 fused rings as C5a inhibitors (2023-10-03),

12. 11708326 - Immunomodulator compounds (2023-07-25),

13. 11684606 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 (2023-06-27),

14. 11608336 - Prodrugs of fused-bicyclic C5aR antagonists (2023-03-21),

15. 11485737 - Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors (2022-11-01),

Title: The Innovative Journey of Venkat Mali

Introduction: Venkat Mali, a talented inventor based in Cupertino, CA, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Venkat Mali's recent patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary wearable device for health monitoring, and a unique blockchain solution for secure data management.

Career Highlights: With a background in computer science and engineering, Venkat Mali has worked for top tech companies in Silicon Valley, where he honed his skills in developing innovative solutions. He has been recognized for his out-of-the-box thinking and problem-solving abilities.

Collaborations: Throughout his career, Venkat Mali has collaborated with leading researchers, engineers, and designers to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Venkat Mali's passion for innovation and his dedication to pushing the boundaries of technology make him a standout inventor in the competitive tech industry. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.